398 related articles for article (PubMed ID: 26603347)
21. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
[TBL] [Abstract][Full Text] [Related]
22. Microneedles for vaccine delivery: challenges and future perspectives.
Shin CI; Jeong SD; Rejinold NS; Kim YC
Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
[TBL] [Abstract][Full Text] [Related]
23. Parameter optimization toward optimal microneedle-based dermal vaccination.
van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
[TBL] [Abstract][Full Text] [Related]
24. Targeting the skin for microneedle delivery of influenza vaccine.
Koutsonanos DG; Compans RW; Skountzou I
Adv Exp Med Biol; 2013; 785():121-32. PubMed ID: 23456844
[TBL] [Abstract][Full Text] [Related]
25. Successful application of large microneedle patches by human volunteers.
Ripolin A; Quinn J; Larrañeta E; Vicente-Perez EM; Barry J; Donnelly RF
Int J Pharm; 2017 Apr; 521(1-2):92-101. PubMed ID: 28216463
[TBL] [Abstract][Full Text] [Related]
26. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
Prausnitz MR
Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
[TBL] [Abstract][Full Text] [Related]
27. Microneedle technology for potential SARS-CoV-2 vaccine delivery.
McNamee M; Wong S; Guy O; Sharma S
Expert Opin Drug Deliv; 2023 Jun; 20(6):799-814. PubMed ID: 37128730
[TBL] [Abstract][Full Text] [Related]
28. Delivery systems for intradermal vaccination.
Kim YC; Jarrahian C; Zehrung D; Mitragotri S; Prausnitz MR
Curr Top Microbiol Immunol; 2012; 351():77-112. PubMed ID: 21472533
[TBL] [Abstract][Full Text] [Related]
29. Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.
Lutton RE; Moore J; Larrañeta E; Ligett S; Woolfson AD; Donnelly RF
Drug Deliv Transl Res; 2015 Aug; 5(4):313-31. PubMed ID: 26022578
[TBL] [Abstract][Full Text] [Related]
30. Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.
Naito S; Ito Y; Kiyohara T; Kataoka M; Ochiai M; Takada K
Vaccine; 2012 Feb; 30(6):1191-7. PubMed ID: 22172508
[TBL] [Abstract][Full Text] [Related]
31. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
Wedlock PT; Mitgang EA; Elsheikh F; Leonard J; Bakal J; Welling J; Crawford J; Assy E; Magadzire BP; Bechtel R; DePasse JV; Siegmund SS; Brown ST; Lee BY
Vaccine; 2019 Jan; 37(4):645-651. PubMed ID: 30578088
[TBL] [Abstract][Full Text] [Related]
32. Acrylated adhesive proteinic microneedle patch for local drug delivery and stable device implantation.
Yang JW; Lee J; Song KI; Park D; Cha HJ
J Control Release; 2024 Jul; 371():193-203. PubMed ID: 38782066
[TBL] [Abstract][Full Text] [Related]
33. Devices for intradermal vaccination.
Kis EE; Winter G; Myschik J
Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
[TBL] [Abstract][Full Text] [Related]
34. Microneedles: A New Generation Vaccine Delivery System.
Menon I; Bagwe P; Gomes KB; Bajaj L; Gala R; Uddin MN; D'Souza MJ; Zughaier SM
Micromachines (Basel); 2021 Apr; 12(4):. PubMed ID: 33919925
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques.
Perez Cuevas MB; Kodani M; Choi Y; Joyce J; O'Connor SM; Kamili S; Prausnitz MR
Bioeng Transl Med; 2018 Sep; 3(3):186-196. PubMed ID: 30377659
[TBL] [Abstract][Full Text] [Related]
36. Opportunities and challenges in delivering influenza vaccine by microneedle patch.
Jacoby E; Jarrahian C; Hull HF; Zehrung D
Vaccine; 2015 Sep; 33(37):4699-704. PubMed ID: 25842218
[TBL] [Abstract][Full Text] [Related]
37. Development of a thermostable microneedle patch for influenza vaccination.
Mistilis MJ; Bommarius AS; Prausnitz MR
J Pharm Sci; 2015 Feb; 104(2):740-9. PubMed ID: 25448542
[TBL] [Abstract][Full Text] [Related]
38. Technology update: dissolvable microneedle patches for vaccine delivery.
Rodgers AM; Cordeiro AS; Donnelly RF
Med Devices (Auckl); 2019; 12():379-398. PubMed ID: 31572025
[TBL] [Abstract][Full Text] [Related]
39. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
[TBL] [Abstract][Full Text] [Related]
40. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.
Andrianov AK; DeCollibus DP; Gillis HA; Kha HH; Marin A; Prausnitz MR; Babiuk LA; Townsend H; Mutwiri G
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18936-41. PubMed ID: 19864632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
